Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Crispr stock reversed lower Monday, while Intellia stock surged, on promising updates for their gene-editing efforts.

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...